bioRxiv / medRxiv
open access
CC0 1.0
A Low Containment CCHFV Entry Screening Platform Identifies Compounds with Antiviral Activity against Authentic CCHFV
Backgrounds Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne nairovirus that can cause severe human disease in the endemic areas, and no licensed antiviral is broadly available. Antiviral discovery is constrained by the requirement to study authentic CCHFV under biosafety level 4 (BSL-4
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Application of next generation phage display technology to develop virus specific peptide-based serology diagnostics for mosquito-borne and tick-borne flaviviruses#990170
- Study of Tecovirimat for Human Mpox Virus#245589
- Study on Dynamic Changes of the Maternal Anti-EV71 and Anti-CVA16 Antibody Levels in Infants and Young Children#1073996
- A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19#1126146
- Spanish Registry of Pregnant Women With COVID-19#1085676
Record · ID 1110904
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive